Cargando…

Impact of SARS-CoV-2 Genetic Blueprints on the Oral Manifestation of COVID-19: A Case Report

Nonsegmented positive-sense RNA enveloped RNA severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus can result in coronavirus disease 2019 (COVID-19). This virus is from β-coronaviridae family of viruses. The common signs and symptoms of COVID-19 include pyrexia, cough, dyspnea, fatigue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khodavirdipour, Amir, Asadimanesh, Mahsa, Masoumi, Seyed Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8635811/ https://www.ncbi.nlm.nih.gov/pubmed/34877577 http://dx.doi.org/10.1055/s-0041-1735538

Ejemplares similares

A Blueprint to Control the SARS-CoV-2 Pandemic
por: O’Horo, John C., et al.
Publicado: (2021)

Investigating Neurological Manifestations of SARS-CoV-2
por: Mozafar, Maryam, et al.
Publicado: (2021)

Potential of Bacillus subtilis Against SARS-CoV-2 – A Sustainable Drug Development Perspective
por: Khodavirdipour, Amir, et al.
Publicado: (2022)

Oral manifestations in SARS-CoV-2 infection
por: Tuter, Gulay, et al.
Publicado: (2022)

SARS-CoV-2 triggering autoimmune diseases
por: Mobasheri, Leila, et al.
Publicado: (2022)

SARS-CoV-2 and Oral Manifestation: An Observational, Human Study
por: Sinjari, Bruna, et al.
Publicado: (2020)

Are oral manifestations related to SARS-CoV-2 mediated hemolysis and anemia?
por: Sarode, Gargi S., et al.
Publicado: (2021)

The RAAS Axis and SARS-CoV-2: From Oral to Systemic Manifestations
por: Maranduca, Minela Aida, et al.
Publicado: (2022)

Systematic review of the oral manifestations produced by the SARS-CoV-2 vaccine
por: López-Carriches, Carmen, et al.
Publicado: (2023)

A blueprint for academic labs to produce SARS-CoV-2 RT-qPCR test kits
por: Mascuch, Samantha J., et al.
Publicado: (2020)

A blueprint for academic laboratories to produce SARS-CoV-2 quantitative RT-PCR test kits
por: Mascuch, Samantha J., et al.
Publicado: (2020)

Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs
por: Malone, Brandon, et al.
Publicado: (2020)

Oral Manifestations in SARS-CoV-2 Positive Patients: A Systematic Review
por: Nijakowski, Kacper, et al.
Publicado: (2022)

Neurotropism of SARS-CoV 2: Mechanisms and manifestations
por: Conde Cardona, Giancarlos, et al.
Publicado: (2020)

Update on Neurological Manifestations of SARS-CoV-2
por: Valiuddin, Hisham M., et al.
Publicado: (2020)

Gastrointestinal manifestations and SARS-CoV-2 infection
por: Pizuorno, Antonio, et al.
Publicado: (2021)

Cutaneous Manifestations of SARS-CoV-2 Infection
por: Huynh, Thy, et al.
Publicado: (2022)

Neuropsychiatric manifestations of SARS-CoV-2 infection
por: Nogueira, V., et al.
Publicado: (2021)

Review of Neurological Manifestations of SARS-CoV-2
por: ., Priyal, et al.
Publicado: (2023)

The oral manifestations and related mechanisms of COVID-19 caused by SARS-CoV-2 infection
por: Lin, Weiming, et al.
Publicado: (2023)

Ocular manifestations of SARS-CoV-2: Literature review()
por: Pérez-Bartolomé, F., et al.
Publicado: (2021)

Skin Manifestation of SARS-CoV-2: The Italian Experience
por: Cazzato, Gerardo, et al.
Publicado: (2021)

SARS‑CoV‑2 and Seizure: An Insight Into the Pathophysiology
por: Ahadiat, Seyed Amir Abbas, et al.
Publicado: (2023)

Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?
por: DEHGHANI, Arezoo, et al.
Publicado: (2020)

Lessons learned from SARS-CoV and MERS-CoV: FDA-approved Abelson tyrosine-protein kinase 2 inhibitors may help us combat SARS-CoV-2
por: Nabavi, Seyed Fazel, et al.
Publicado: (2020)

SARS-CoV-2: Overview and Its Impact on Oral Health
por: Ting, Miriam, et al.
Publicado: (2021)

Genetics in ophthalmology: molecular blueprints of retinoblastoma
por: Marković, Leon, et al.
Publicado: (2023)

Vitamin D Deficiency in Both Oral and Systemic Manifestations in SARS-CoV-2 Infection: Updated Review
por: Pinzariu, Alin Constantin, et al.
Publicado: (2022)

The Blueprint
por: Conant, Douglas
Publicado: (2020)

Dermatological aspects of SARS-CoV-2 infection: mechanisms and manifestations
por: Garduño-Soto, Myriam, et al.
Publicado: (2020)

Neurological Aspects of SARS-CoV-2 Infection: Mechanisms and Manifestations
por: Guadarrama-Ortiz, Parménides, et al.
Publicado: (2020)

Neurological manifestations in COVID‐19 caused by SARS‐CoV‐2
por: Baig, Abdul Mannan
Publicado: (2020)

Current opinion in neurological manifestations of SARS-CoV-2 infection
por: Engin, Ayse Basak, et al.
Publicado: (2021)

Diagnostic value of cutaneous manifestation of SARS‐CoV‐2 infection(*)
por: Visconti, A., et al.
Publicado: (2021)

Manifestations and Mechanism of SARS-CoV2 Mediated Cardiac Injury
por: Xu, Si-chi, et al.
Publicado: (2022)

Cerebrovascular Manifestations of SARS-CoV-2: A Comprehensive Review
por: Stefanou, Εleni, et al.
Publicado: (2023)

Co-infection of ST2(IP) carbapenem-resistant Acinetobacter baumannii with SARS-CoV-2 in the patients admitted to a Tehran tertiary referral hospital
por: Abdollahi, Alireza, et al.
Publicado: (2021)

Insights into Plasmodium and SARS-CoV-2 co-infection driven neurological manifestations
por: Indari, Omkar, et al.
Publicado: (2021)

Genetic blueprint of the zoonotic pathogen Toxocara canis
por: Zhu, Xing-Quan, et al.
Publicado: (2015)

Cutaneous Manifestations in the Context of SARS-CoV-2 Infection (COVID-19)()
por: Carrascosa, J.M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_h3lg6fj1o694ufqlpcearn4hah